Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-16 Sale |
2024-05-20 5:03 pm |
Enliven Therapeutics Inc. | ELVN | Gupta Rishi Director 10% Owner |
1,033,300 | $22.14 | $22,877,262 | 7,663,349 (Indirect) |
View |
| 2023-07-20 Purchase |
2023-07-24 4:40 pm |
Turnstone Biologics Corp. | TSBX | Gupta Rishi Director 10% Owner |
416,666 | $12 | $4,999,992 | 3,099,265 (Indirect) |
View |
| 2023-05-11 Sale |
2023-05-15 6:06 pm |
Verona Pharma plc | VRNA | Gupta Rishi Director |
482,913 | $20.58 | $9,938,132 | 3,777,778 (Indirect) |
View |
| 2022-12-22 Sale |
2022-12-27 5:32 pm |
Verona Pharma plc | VRNA | Gupta Rishi Director |
6,139,864 | $22.15 | $136,000,855 | 34,085,528 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-06 Option Award |
2025-02-10 5:36 pm |
N/A 2035-02-06 |
Enliven Therapeutics Inc. | ELVN | Gupta Rishi Director 10% Owner |
20,491 | $0 | 20,491 (Direct) |
View |
| 2024-06-03 Option Award |
2024-07-02 4:45 pm |
N/A 2034-06-02 |
Turnstone Biologics Corp. | TSBX | Gupta Rishi Director 10% Owner |
12,770 | $0 | 12,770 (Direct) |
View |
| 2024-02-13 Option Award(A) |
2024-02-20 7:30 pm |
N/A 2034-02-13 |
Enliven Therapeutics Inc. | ELVN | Gupta Rishi Director 10% Owner |
23,364 | $0 | 23,364 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 8:50 pm |
N/A 2034-02-12 |
Enliven Therapeutics Inc. | ELVN | Gupta Rishi Director 10% Owner |
16,835 | $0 | 16,835 (Direct) |
View |
| 2023-10-16 Option Award |
2023-10-17 6:40 pm |
N/A 2033-10-15 |
Turnstone Biologics Corp. | TSBX | Gupta Rishi Director 10% Owner |
25,540 | $0 | 25,540 (Direct) |
View |
| 2023-07-20 Conversion |
2023-07-24 4:40 pm |
N/A N/A |
Turnstone Biologics Corp. | TSBX | Gupta Rishi Director 10% Owner |
5,365,198 | $0 | 3,099,265 (Indirect) |
View |
Ownership |
2023-07-20 9:51 pm |
N/A N/A |
Turnstone Biologics Corp. | TSBX | Gupta Rishi Director 10% Owner |
0 | $0 | 2,682,599 (Indirect) |
View |
| 2023-05-17 Exercise |
2023-05-19 4:12 pm |
N/A 2032-06-01 |
Enliven Therapeutics Inc. | ELVN | Gupta Rishi Director 10% Owner |
2,125 | $0 | 8,951,463 (Indirect) |
View |
| 2023-05-17 Exercise |
2023-05-19 4:12 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Gupta Rishi Director 10% Owner |
2,125 | $4.28 | 8,951,463 (Indirect) |
View |
| 2023-04-28 Option Award |
2023-04-28 4:20 pm |
N/A 2033-04-27 |
Verona Pharma plc | VRNA | Gupta Rishi Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-04-06 8:18 pm |
N/A 2033-02-23 |
Enliven Therapeutics Inc. | ELVN | Gupta Rishi Director 10% Owner |
27,567 | $0 | 27,567 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 9:53 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Gupta Rishi Director 10% Owner |
7,899,572 | $0 | 288,114 (Indirect) |
View |
| 2022-04-28 Option Award |
2022-04-29 4:45 pm |
N/A 2032-04-27 |
Verona Pharma plc | VRNA | Gupta Rishi Director |
200,000 | $0 | 200,000 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-10 4:46 pm |
N/A 2031-08-08 |
Verona Pharma plc | VRNA | Gupta Rishi Director |
64,000 | $0 | 64,000 (Direct) |
View |
Ownership |
2021-01-05 7:22 pm |
N/A N/A |
Verona Pharma plc | VRNA | Gupta Rishi Director 10% Owner |
0 | $0 | 42,093,331 (Indirect) |
View |
Ownership |
2021-01-04 8:20 pm |
N/A 2030-09-24 |
Verona Pharma plc | VRNA | Gupta Rishi Director |
0 | $0 | 185,600 (Direct) |
View |